← FDA DRUG APPROVALS

FDA ANDA · ANDA204299

ZOLPIDEM TARTRATE

Sponsor: NOVEL LABS INC

APPLICATION
ANDA204299
TYPE
ANDA
ORIGINAL APPROVAL
2015-06-03
LATEST ACTION
2019-11-29
ROUTE
SUBLINGUAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ZOLPIDEM TARTRATEPrescription
ZOLPIDEM TARTRATE 1.75MG · TABLET · SUBLINGUAL
ZOLPIDEM TARTRATEPrescription
ZOLPIDEM TARTRATE 3.5MG · TABLET · SUBLINGUAL

Approval history

2019-11-29Labeling · Supplement 7 · standardAP
2019-11-29Labeling · Supplement 1 · standardAP
2015-06-03UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →